» Authors » Amy Anderson

Amy Anderson

Explore the profile of Amy Anderson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 902
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Manwani D, Burnett A, Paulose J, Yen G, Burton T, Anderson A, et al.
EJHaem . 2022 Dec; 3(4):1135-1144. PMID: 36467832
Complications associated with sickle cell disease (SCD) that are highly impactful for patients but until recently have been less understood include priapism, nephropathy, and neurologic injury. We conducted a retrospective...
12.
Feinstein J, Bruckner A, Chastek B, Anderson A, Roman J
Orphanet J Rare Dis . 2022 Sep; 17(1):367. PMID: 36175960
Background: Dystrophic epidermolysis bullosa (DEB) is a serious, ultra-rare, genetic blistering disease that requires a multidisciplinary care team and lifelong, proactive disease management. To organize and optimize care, we comprehensively...
13.
Anderson-Coughlin B, Shearer A, Omar A, Litt P, Bernberg E, Murphy M, et al.
Sci Total Environ . 2022 Mar; 830:154619. PMID: 35306079
Wastewater surveillance has been a useful tool complementing clinical testing during the COVID-19 pandemic. However, transitioning surveillance approaches to small populations, such as dormitories and assisted living facilities poses challenges...
14.
Egolf S, Zou J, Anderson A, Simpson C, Aubert Y, Prouty S, et al.
Sci Adv . 2021 Dec; 7(50):eabj9141. PMID: 34890228
The epigenetic regulator, (), has been described as an essential gene in both humans and mice. In addition, it is one of the most commonly mutated genes in all of...
15.
Keogh A, Argent R, Anderson A, Caulfield B, Johnston W
J Neuroeng Rehabil . 2021 Sep; 18(1):138. PMID: 34526053
Background: The World Health Organisation's global strategy for digital health emphasises the importance of patient involvement. Understanding the usability and acceptability of wearable devices is a core component of this....
16.
Yu J, Lal L, Anderson A, DuCharme M, Parasuraman S, Weisdorf D
Curr Med Res Opin . 2021 Feb; 37(5):755-759. PMID: 33615925
Background: Chronic graft-versus-host disease (cGVHD) is the most serious non-relapse complication affecting long-term allogeneic hematopoietic cell transplantation (HCT) survivors. We describe healthcare resource utilization (HCRU) and costs in patients with...
17.
Yoong S, Hall A, Stacey F, Grady A, Sutherland R, Wyse R, et al.
Implement Sci . 2020 Jul; 15(1):50. PMID: 32611354
Background: Nudge interventions are those that seek to modify the social and physical environment to enhance capacity for subconscious behaviours that align with the intrinsic values of an individual, without...
18.
Yu J, Lal L, Anderson A, DuCharme M, Parasuraman S, Weisdorf D
Support Care Cancer . 2020 Mar; 28(11):5491-5499. PMID: 32172407
Purpose: The contribution of acute graft-versus-host disease (GVHD) to healthcare resource utilization (HCRU) and costs following allogeneic hematopoietic cell transplantation (HCT) has not been extensively investigated. The objective of this...
19.
Toth P, Granowitz C, Hull M, Anderson A, Philip S
Lipids Health Dis . 2019 Sep; 18(1):175. PMID: 31526399
Background: A decade ago, statin persistence was < 50% after 1 year, and recent short-term analyses have revealed very little progress in improving statin persistence, even in patients with a...
20.
Egolf S, Aubert Y, Doepner M, Anderson A, Maldonado-Lopez A, Pacella G, et al.
Cell Rep . 2019 Aug; 28(8):1981-1992.e7. PMID: 31433976
Self-renewing somatic tissues depend upon the proper balance of chromatin-modifying enzymes to coordinate progenitor cell maintenance and differentiation, disruption of which can promote carcinogenesis. As a result, drugs targeting the...